Bridgewater Advisors’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$205K Sell
4,762
-1,466
-24% -$65.5K 0.01% 475
2026
Q1
$264K Buy
6,228
+1,592
+34% +$74.2K 0.02% 389
2025
Q4
$214K Sell
4,636
-756
-14% -$37.5K 0.01% 430
2025
Q3
$267K Sell
5,392
-828
-13% -$40K 0.02% 374
2025
Q2
$307K Sell
6,220
-1,053
-14% -$53.8K 0.02% 332
2025
Q1
$391K Buy
+7,273
New +$394K 0.03% 275

Other funds holding SNY

Bridgewater Advisors's SNY Position: Q2 2026 in Review

Bridgewater Advisors reduced its Sanofi (SNY) stake by 24% in Q2 2026, selling an estimated $65.5K and leaving 4,762 shares worth $205K. The position accounts for 0.01% of the portfolio, ranked #475.

Bridgewater Advisors first reported a position in SNY in Q1 2025 and has held it in 6 quarters since. The position peaked at $391K in Q1 2025. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Bridgewater Advisors held 4,762 shares of Sanofi worth $205K as of Q2 2026.
  • Bridgewater Advisors sold 1,466 Sanofi shares in Q2 2026, an estimated $65.5K.
  • Sanofi made up 0.01% of Bridgewater Advisors's portfolio in Q2 2026, its #475 holding.
  • Bridgewater Advisors first reported a position in Sanofi in Q1 2025 and has held it in 6 quarters since.
  • Bridgewater Advisors's Sanofi position peaked at $391K in Q1 2025.
  • 716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Bridgewater Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.